Ubiquitin and ubiquitin-like modifications of the p53 family.
about
The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73Plk1-mediated phosphorylation of Topors regulates p53 stability60th residues of ubiquitin and Nedd8 are located out of E2-binding surfaces, but are important for K48 ubiquitin-linkageNeoplasia: Where We Have Been and Where We Are GoingDelta(9)-tetrahydrocannabinol regulates the p53 post-translational modifiers Murine double minute 2 and the Small Ubiquitin MOdifier protein in the rat brainNeoplasia: the second decade.A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.The molecular determinants for distinguishing between ubiquitin and NEDD8 by USP2.SUMOylation and de-SUMOylation in response to DNA damage.Covalent NEDD8 conjugation increases RCAN1 protein stability and potentiates its inhibitory action on calcineurin.Beclin-1-p53 interaction is crucial for cell fate determination in embryonal carcinoma cells.Residues 240-250 in the C-terminus of the Pirh2 protein complement the function of the RING domain in self-ubiquitination of the Pirh2 protein.Deficiency of a potential 3p21.3 tumor suppressor gene UBE1L (UBA7) does not accelerate lung cancer development in K-rasLA2 mice.Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptinRegulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation.UBE4B: a promising regulatory molecule in neuronal death and survival.Coping with stress: multiple ways to activate p53.Therapeutic prospects for p73 and p63: rising from the shadow of p53.1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma modelRegulatory feedback loop between TP73 and TRIM32.p53 family: Therapeutic targets in neuroblastoma.Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.Lysine-specific modifications of p53: a matter of life and death?A nanotechnological, molecular-modeling, and immunological approach to study the interaction of the anti-tumorigenic peptide p28 with the p53 family of proteinsRLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.Transcriptional activity of TAp63 promoter is regulated by c-jun.WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.Modification of Drosophila p53 by SUMO modulates its transactivation and pro-apoptotic functions.Isopeptidases in anticancer therapy: looking for inhibitors.Neoplasia: An Anniversary of Progress.Neddylation positively regulates the ubiquitin E3 ligase activity of parkin.
P2860
Q24311644-D49B5788-8739-47B3-BC82-AC4786E7E690Q24314588-95731862-437B-4807-8669-DEEA2A433EB8Q27657571-1E264804-9EB5-47F0-9FC1-ECFDE01352F0Q28395095-74E28931-7D77-4F5E-BA2E-78C8DA976FBBQ28578074-F2880267-6060-4257-952C-58B2C9C314CFQ30484000-480505FE-7E2E-4115-900D-DF0D2EFA3ECEQ30497990-8761D921-6411-426C-8A54-C7DC767C1FE2Q33720055-720AE4E0-2F83-4F71-9BE3-1D0BAFF0EBFCQ33870712-D52CABAC-95A4-4E2B-A082-FE7F6202D3E4Q34464956-0FEB56BD-6C42-429A-8DC5-8EE734595A89Q34473682-685EC5BA-DA78-4AA0-AD61-5BEA8442C0C5Q35075426-8D785E92-4F8E-462E-9B63-35D614AD4DDBQ35108242-1B6BBFCC-54C3-4F94-929C-3B21F9C4CDE5Q36496801-6135E48A-E2B7-460B-8126-65535F2287B2Q36516034-31222B26-FE2A-4CDF-8E9A-D38610206A30Q36538525-E72C351C-C6D1-473B-B03E-00B1559DDAB4Q36745375-57357B03-5DA5-497D-8200-64D7A9F770C8Q36979908-C9D94B34-5568-44DD-B05A-EB0EB4DA0219Q36982956-AC8E5B80-BCF4-4577-A167-8C0BE75F666AQ37062004-8FE34F36-802A-4D91-BD33-FF87074619FAQ37707387-26D8065C-9107-4E39-B20C-58719A51BB77Q38016718-4B661035-E538-42D5-B302-41BE5F7A38D1Q38168223-E2CCDE7D-A788-4903-8238-B0C4CC470D53Q38747114-C7FD3032-A524-402D-92F6-1E1A5366657AQ39225715-8B7FA482-BA18-4ADA-AADD-4FFC3DE69079Q39428299-CAC77D3C-DB72-4DBE-999E-295843207F39Q39683473-A2C53AE6-9606-46EC-B6B8-77520C164316Q39937434-44B89D57-9B57-46DD-A7EA-E0BE1F3F6B64Q40423291-453E616D-459D-4ED1-9795-C3EFF7C35BEEQ41466923-45E545E8-3588-40C2-8D01-5B6D7B4BF247Q46932476-35F5EC29-F2E6-4B0F-B0A6-72B23CD06CBEQ48695224-6F7A45E4-0BC1-4BF4-986C-07E8019B105E
P2860
Ubiquitin and ubiquitin-like modifications of the p53 family.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Ubiquitin and ubiquitin-like modifications of the p53 family.
@ast
Ubiquitin and ubiquitin-like modifications of the p53 family.
@en
type
label
Ubiquitin and ubiquitin-like modifications of the p53 family.
@ast
Ubiquitin and ubiquitin-like modifications of the p53 family.
@en
prefLabel
Ubiquitin and ubiquitin-like modifications of the p53 family.
@ast
Ubiquitin and ubiquitin-like modifications of the p53 family.
@en
P2860
P356
P1433
P1476
Ubiquitin and ubiquitin-like modifications of the p53 family.
@en
P2093
Ian R Watson
Meredith S Irwin
P2860
P304
P356
10.1593/NEO.06439
P577
2006-08-01T00:00:00Z